The presence of effector immune cells in human CD200 positive tumor samples supports the CD200 immune checkpoint as a novel therapeutic targetMark Hamilton,Rui-Ru Ji, Tony Arulanandam, Sharon BarrJOURNAL FOR IMMUNOTHERAPY OF CANCER（2017）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
